26 Oct 2021
Mereo Receives U.S. Orphan Drug Designation for alvelestat in Treatment of AATD
DOWNLOAD PDF (135KB)
13 Oct 2021
Mereo BioPharma, OIFE and OIF announce completion of the IMPACT Survey enrollment
View Press Release DOWNLOAD PDF (234KB)
01 Oct 2021
Mereo BioPharma and Ultragenyx Present Data from the Phase 2b ASTEROID Study of UX143 (setrusumab) in Osteogenesis Imperfecta (OI) at the American Society for Bone and Mineral Research (ASBMR) 2021 Annual Meeting
View Press Release DOWNLOAD PDF (219KB)
20 Sep 2021
Mereo BioPharma Announces Appointment of Dr. Pierre Jacquet to Board of Directors
VIEW PRESS RELEASE DOWNLOAD PDF (54KB)
10 Sep 2021
Mereo BioPharma to Participate in Three Upcoming Investor Conferences
View Press Release Download PDF (50KB)

Corporate Presentation

View our latest Corporate Presentation

CORPORATE PRESENTATION

Our Mission

Our mission is to provide new therapies to patients with life limiting oncology and rare diseases that have few, if any, other treatment options.

View more about us